1、Global Talent SolutionsPharma Talent Market TrendsandDynamics in China2025 H250%turnover at commercial executive level among 12 leading MNC Pharmacoin China.Beyond gauging the surge in demand for certain roles and the stabilization of others,the realm of executive positions warrants a closer look,es

2、pecially given their inherent volatility.The turnover rate among top executives has been notably on the rise,a trend that demands attention due to its potential impact on corporate strategy and continuity.In 2024,6 out of the 12 leading MNC Pharmaco replaced theirPresidents/GMsin China.100%of those

3、China Presidents/GMs were filled internally 2 were internally promoted from local positions,while 10 were internally transferred from regional and global teams.During the second half of 2024 and the first half of 2025，a total of 22 BUVPs out of approximately 50 changed their jobs,indicating a signif

4、icant reshuffling at this position.This high turnover rate suggests that companies are actively reevaluating and reorganizing their business units to better align with strategic goals.High turnover rate at the executivelevelin commercial sectorSignificantlylow turnover rate of 9%for R&D executives a

5、mong the 12 leading MNC Pharmacoin 2025 H1What keeps R&D executives less active in the job market?1Commitment for long-term R&D strategy and alignment.2High sense of belonging and satisfaction with present employer.3Seeing the tangible results is highly fulfilling.4Value the collaborations in the in

6、ternal established professional networks.5Risk aversion and focus on long-term career goal.39 R&D functional-head level leaders were interviewed by Robert Walters.33%8%16%17%13%8%R&D executive turnover rate 20242025H1Whats driving the Recruitment Boom at MNC Pharmacoin China for 2025?2025 H1 positio